Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a parasite drug clear flat warts? new trial investigates

NCT ID NCT07710638

Disease control Sponsor: Al-Azhar University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This trial tests whether ivermectin, a drug used for parasitic infections, can treat flat warts (plane warts). Researchers will give some participants ivermectin (by mouth and on the skin) and others a placebo to see if the drug helps clear the warts. The study includes people of all ages over 5 years old who have not treated their warts in the last month.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ivermectin (oral and topical)
What this could lead to
If effective, ivermectin could offer a new, affordable treatment option for flat warts.
What could go wrong
This is a small, early-phase trial, and ivermectin's antiviral effects against warts are not yet proven. Results may not lead to a standard treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: • Clinical and dermoscopic diagnosis of the plane warts. * No prior treatment for warts in the last 4 weeks. * Patients of both sex (male - female) * Age more than 5 years or weight more than 15 kg. Exclusion Criteria: * • Patients with other types of warts (e.g., common, plantar, genital). * History of hypersensitivity or allergy to ivermectin or its components. * Patients who have received systemic immunosuppressive therapy within the last 3 months. * Presence of chronic skin conditions that may interfere with evaluation (e.g., eczema, psoriasis). * Patients with immunodeficiency disorders (e.g., HIV, organ transplant recipients). * Pregnant or lactating females. * Patients currently on systemic antiviral or immunomodulatory treatment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Plane warts are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

plantar wart

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Plane warts

Contacts and locations

Locations

  • Department of Dermatology , Al-Azhar university hospital

    Asyut, Egypt